• The UK’s first and only Centre of Excellence for childhood lupus and coordinating centre for the UK’sJSLE Study Group, a multi-disciplinary translational research group investigating this archetypal, paediatric systemic autoimmune disease.
  • A national centre for head and face surgery.

  • A Centre of Excellence for children with cancer, heart, spinal and brain disease.

  • A nationally commissioned respiratory Extracorporeal Membrane Oxygenation (ECMO) centre.

  • A designated Major Trauma Centre, and is one of four national Children’s Epilepsy Surgical Centres.


  • One of only four centres nationally to provide epilepsy surgery and one of only two accredited major trauma centres in the North West.

  • A centre of excellence for children with cancer, heart, spinal and brain disease.

  • Nationally commissioned as a respiratory Extracorporeal Membrane Oxygenation (ECMO) centre.

  • The lead centre for the the Cheshire, Merseyside and North Wales Medicines for Children Research Network (MCRN).


Alder Hey is the UK’s premier centre for applied clinical research in children and young people, including the first and only Centre of Excellence for childhood lupus and coordinating centre for the UK's JSLE Study Group. The Trust has the UK's only National Experimental Arthritis Treatment Centre for Children (EATC) working with worldwideinstitutions and the pharmaceutical industry to speed up treatments.

  • An extensive research programme is supported by a Clinical Research Business Unit of highly experienced and skilled staff expert in the delivery of complex portfolios of all types of clinical research in children and young people.  The trust and the University of Liverpool have developed an integrated strategy for child health with research themes ( mapped against Liverpool Health Partners Clinical Academic Programmes.

    Lead: Clinical Research Business Unit


  • The NIHR Alder Hey  Clinical Research Facility for Experimental Medicine supports the delivery of leading edge, high quality, early phase and translational research in babies, children and young people. The unit is fully staffed with expert paediatric clinical research nurses, specialist pharmacists, a business manager, quality assurance manager, play specialist and research fellows. The facility offers children and families the opportunity to participate in phase l and ll studies requiring inpatient or daycase stays. The CRF places Alder Hey at the forefront of improving the health and well-being of children and young people.

    Lead: Professor Michael Beresford


  • The Alder Hey Children’s Nursing Research Unit is a collaboration between Alder Hey Children’s NHS Foundation Trust, the University of Central Lancashire, Edge Hill University and Liverpool John Moore’s University. The Children’s Nursing Research Unit supports a number of NIHR funded fellows and is helping to create clinical research careers for nurses.

    Lead: Professor Bernie Carter


  • Alder Hey leads the field in drug safety in children and has recently completed a NIHR programme grant for £2m for work in this area. With the Department of Pharmacology, University of Liverpool, Alder Hey is supporting the development of Paediatric Clinical Pharmacology as a national strength led from Liverpool.

    Lead: Professor Matthew Peak


  • Alder Hey and the University of Liverpool hosts of the NIHR Children Research Network (CRN):Children, Alder Hey is the UK's leading recruiter to NIHR CRN:Children Studies, with over 20,000 babies and children having partcipated in studies on the NIHR CRN portfolio.  

    Lead: Dr Charlie Orton 

  • Building on its expertise in children's medicines, the Paediatric Medicines Research Unit (PRMU) is a collaboration between Alder hey, Liverpool Women's Hospital and Liverpool John Moore's University. The PRMU focuses on use of paediatric formulations and the practice of pharmacy within paediatrics. The PMRU has a number of doctoral/post-doctoral Pharmacists and PhD students.

    Lead: Professor Matthew Peak

  • The Alder Hey site houses the Medicines for Chhildren Clinical Trials Unit (MC CTU) which is based within the Department of Child Health, Institute of Translational Medicine. The MC CTU has been established to support clinical trials within NIHR CRN:Children and other studies involving children. The MCRN CTU provides advice and support on all aspects of trial design and management.

    Lead: Director of the MCRN CTU, Professor Paula Williamson

    Contact: /Tel: 0151 252 5439

  • The trust has a thriving patient and public involvement and engagement programme for research and, with NIHR CRN:Children, is pioneering methods for the active involvement of children, young people and families in all aspects of research

    Lead: Research Consumer Liaison Manager, Jennifer Newman




  • The trust houses Europe’s only intra-operative 3-T MRI scanner: a pioneering technology for neurosurgery, reducing repeat operations in 90% of cases. This high-resolution magnetic imaging combined with an adjacent state of the art theatre featuring BrainLab image guided navigation systems, enables scans to be carried out in the operating theatre during surgery. This provides the surgeon with highly accurate, real-time information used for navigation and updates on progress.


  • Alder Hey has a number of academic partners including the University of Liverpool, Liverpool John Moores University, University of Central Lancashire, Lancaster University and Edge Hill University.


  • The trust is involved with the Paediatric Cancer Biology Group (Chair, Professor Barry Pizer), formed as a collaboration between Alder Hey clinicians and UoL scientists and now affiliated with the Liverpool CRUK Centre.
  • The trust is greatly involved in development of International Child Health research. Examples include Professor Atif Rahman’s programme into Child Mental Health in Pakistan, Dr Enitan Carrol’s work in infectious diseases in Malawi, Professor Nigel Cunliffe’s research activities in Africa and Nepal, Mr Chandra’s work in models of eye care of childhood blindness in developing countries and Dr Rachel Kneen’s work on epilepsy services in Nepal.


  • Ground has already broke on the new hospital; "Alder Hey in the Park" which will open in 2015. With a design inspired by children, the new hospital will have leading edge technology, the latest medical equipment and hi-tech educational/entertainment IT. It will also have a new research facility and education centre to ensure Alder Hey leads the next generation of treatments and drugs for children.



  • Alder Hey continues to build on its rich heritage of innovation and firsts; Dr Jackson Rees pioneered the preferred technique in anaesthesia at Alder Hey while Penicillin was first tested at the hospital in 1944 to save a child with pneumonia. Splints and bespoke appliance first made at Alder Hey include the Jones Spinal Frame and the famous Thomas Splint. The most commonly encountered congenital heart defect in the UK was first cured by Alder Hey’s Mr Edwards and the first neonatal unit in the UK was established at Alder Hey. Mr Robert Jones was also knighted for advancements made in X-ray and orthopaedic work at Alder Hey.
  • In recent years Alder Hey was the first paediatric trust to introduce ‘liquid glass’ to reduce hospital acquired infections.


  • The trust recently won a HSJ award for its ‘not touch technique’ to reduce infection rates.
  • Alder Hey Children’s Foundation Trust is the first accredited Investing in Children hospital in the UK.
  • Alder Hey Children’s Foundation Trust is a top performing trust. It is an NHSLA Level 3 organisation (the highest possible rating for clinical risk management) and is registered with the Care Quality Commission without conditions.
  • Since becoming a Foundation Trust in 2008, ratings from regulator Monitor have generally been among the highest available.

Eaton Road
West Derby
L12 2AP


Staff 2800
In patients 47627
Out patients 169761
Beds 296
A&E 57437
Go Back

Sign up for our newsletter


Sign up to receive our free, quarterly e-mail newsletter for news and information from LHP

We won’t use your details for any other purpose, and we won’t pass them on to any other organisation.